Royal Philips Electronics (NYSE:PHG) is adding a robotic system to its treatment options for clogged heart arteries in a new pact with Natick, Mass.-based Corindus Inc.
The two companies entered what they’re calling an "alliance agreement" in which Philips adds Corindus’ robotic-assisted system for the minimally invasive treatment of obstructed coronary arteries to its offering of cardiology devices percutaneous coronary intervention. Corindus’ technology complements Philips’ offering of interventional imaging and clinical informatics products, the comapnies said.
The financial terms of the agreement were not disclosed, but Philips did acquire a minority stake in Corindus, according to the companies.
Here’s a roundup of companies announcing new distribution deals and other joint ventures.
- Neuralstem signs memorandum of understanding for stroke program in China
Neuralstem Inc. (NYSE Amex:CUR) announced it has signed a Memorandum of Understanding with BaYi Brain Hospital in Beijing, China. Under the agreement, BaYi Brain and Neuralstem will jointly prepare a clinical protocol for treatment of motor deficits due to ischemic stroke.
Read more - Velos partners with Comaiba
Velos Inc. announced an initiative to provide solutions for customers in the areas of risk management and compliance monitoring in research, transplant medicine, and biospecimen management. Velos has partnered with Comaiba Inc., a company focused on regulatory monitoring, risk management, and incident management. Velos and Comaiba will work together to help customers increase efficiency and decrease risk as they interpret, document, and execute to regulatory and clinical policies through their Velos-Comaiba Monitoring and Action solutions.
Read more - Dehaier enters agreement to develop home oxygen services
Dehaier Medical Systems Ltd. (NSDQ:DHRM) announced that its wholly owned subsidiary has signed a tripartite strategic cooperation agreement with Taiyo Nippon Sanso Shenwei (Shanghai) Medical Gas Co. Ltd and Beijing Orient Medical Gas Co. Ltd to develop oxygen therapy services for the home use market in Beijing. Leveraging the expertise of each company, this agreement incorporates oxygen production, filling, selling and service for home medical oxygen in Beijing, according to the companies.
Read more - Entegrion licenses clotting bandage to Beeken BioMedical
North Carolina life sciences company Entegrion has licensed its blood-clotting bandage to newly formed Chicago company Beeken BioMedical. Research Triangle Park-based Entegrion developed the bandage, called Stasilon, which is made of a proprietary weave of glass and bamboo fibers, two materials that promote clotting, writes MedCity News.
Read more
